Appian Has Been Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences

By AIT News Desk On Dec 17, 2020

Appian Offers Low-Code Speed and the Power of Automation to Help Drive the Innovation Process in Scientific Research and Drug Discovery

Appian announces that it has joined the INTIENT ecosystem of Accenture partners as a Core Partner. The ecosystem was designed to help independent software vendors (ISVs) and life science companies integrate their work more effectively to accelerate joint drug discovery efforts and improve patient outcomes.

The INTIENT Network is an integral part of Accenture’s INTIENT Platform, which fosters knowledge creation and collaboration across the life sciences industry to improve productivity, efficiency and innovation in drug discovery. Accenture is partnering with Appian to integrate low-code development into the INTIENT platform.

The automation platform Appian low-code allows companies to build applications up to 20 times faster than traditional coding. By providing a single interface that unifies data, processes, people and digital workforce, Appian helps organizations improve digital innovation and optimize business outcomes. Industry leaders trust Appian to improve the customer experience, achieve operational excellence and simplify global risk management and compliance.

Grammarly Announces Set of Integrations to Simplify Workflows and Reduce Complexities Created by App Overload

Jun 10, 2023

Adobe Brings World’s First AI-Accelerated Content Supply Chain Solution to Europe To Fuel Experience-Led Growth

Jun 10, 2023

All-New Adobe Express With Firefly Revolutionizes How Creators and Brands Design and Share Standout Content

Jun 10, 2023

Prev Next 1 of 36,843

“We are proud to work with Accenture to jointly support research, innovation and the achievement of the best possible results in the life sciences industry. globally is why nine of the world’s top 10 pharmaceutical and biotech companies use Appian, ” said Marc Wilson , Appian Founder and Senior Vice President of Global Partnerships and Industries.

As part of the INTIENT partner ecosystem, the Appian platform will be used across all product suites INTIENT Clinical, INTIENT Patient, INTIENT Research and INTIENT Pharmacovigilance.

” Our open network of partners is one of the ways we deliver innovation to our customers through the Accenture INTIENT platform. Appian’s integration into this ecosystem as a core partner will enable faster development of powerful new digital capabilities for better results. for our Life Sciences customers, “said Joe Donahue , Managing Director of Accenture’s Life Sciences practice.